Skip to main content

Table 2 Risk factors for NTM-PD patients and matched controls

From: Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study

 

Cases n (%)

Controls n (%)

p-value cases/controls

Treated NTM-PD n (%)

Untreated NTM-PD n (%)

p-value treated/not treated

Incident population

4447 (25.0)

13,341 (75.0)

 

1433 (25.5)

4195 (74.5)

 

Charlson comorbidity index score (SD)

1.6 (2.5)

0.2 (0.9)

< 0.0001

1.7 (2.7)

1.5 (2.4)

0.2907

Risk factors before NTM-PD diagnosis

 Chronic lower respiratory diseases

1529 (34.4)

359 (2.7)

< 0.0001

428 (29.9)

1,547 (36.9)

 < 0.0001

  COPD (J44)

836 (18.8)

168 (1.3)

< 0.0001

203 (14.2)

887 (21.1)

 < 0.0001

  Bronchiectasis (J47)

472 (10.6)

16 (0.1)

< 0.0001

123 (8.6)

486 (11.6)

0.0016

  Other lower respiratory Chronic diseases

927 (20.8)

245 (1.8)

< 0.0001

277 (19.3)

911 (21.7)

0.0560

 HIV infection

389 (8.7)

30 (0.2)

< 0.0001

212 (14.8)

211 (5.0)

< 0.0001

 Lung cancer and lung graft

252 (5.7)

55 (0.4)

< 0.0001

52 (3.6)

272 (6.5)

< 0.0001

 Bone marrow transplant

60 (1.3)

3 (0.0)

< 0.0001

17 (1.2)

49 (1.2)

0.9558

 Gastro-esophageal reflux disease

131 (2.9)

120 (0.9)

< 0.0001

44 (3.1)

121 (2.9)

0.7184

 Smoking

164 (3.7)

112 (0.8)

< 0.0001

52 (3.6)

146 (3.5)

0.7923

 Other infectious pneumonia

1085 (24.4)

184 (1.4)

< 0.0001

286 (20.0)

1107 (26.4)

< 0.0001

 Tuberculosis

628 (14.1)

14 (0.1)

< 0.0001

   

 Malnutrition

978 (22.0)

261 (2.0)

< 0.0001

   

 Corticoids

2550 (57.3)

4504 (33.8)

< 0.0001

   

 Cystic fibrosis

143 (3.2)

1 (0.0)

< 0.0001

   
  1. SD standard deviation